Strategic Acquisitions (STQN) Cash & Equivalents Growth (5y) (2022 - 2026)
Powered by 
Analysis
Strategic Acquisitions (STQN) Cash & Equivalents Growth (5y) (2022 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Orix | 44.18 Bn | 44.51 Bn | 4.68 Bn |
| 2 | Royalty Pharma | 33.59 Bn | 35.70 Bn | - |
| 3 | Royal Gold | 21.14 Bn | 21.00 Bn | 390.45 Mn |
| 4 | OR Royalties | 6.88 Bn | 6.81 Bn | 82.22 Mn |
| 5 | Encore Capital | 2.11 Bn | 1.93 Bn | 455.04 Mn |
| 6 | Atlanticus Holdings | 1.41 Bn | 851.50 Mn | 686.46 Mn |
| 7 | Jefferson Capital | 1.18 Bn | 1.16 Bn | - |
| 8 | Lufax Holding | 1.04 Bn | -1.23 Bn | - |
| 9 | Upbound | 998.67 Mn | 893.37 Mn | 594.84 Mn |
| 10 | Strategic Acquisitions | 18.20 Mn | 17.95 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 75.17% |
| Dec 31, 2025 | -51.80% |
| Sep 30, 2025 | 54.22% |
| Jun 30, 2025 | 48.21% |
| Mar 31, 2025 | -32.99% |
| Dec 31, 2024 | -18.47% |
| Sep 30, 2024 | -20.51% |
| Jun 30, 2024 | -36.99% |
| Mar 31, 2024 | -21.30% |
| Dec 31, 2023 | -18.27% |
| Sep 30, 2023 | -11.01% |
| Jun 30, 2023 | -9.25% |
| Mar 31, 2023 | -6.22% |
| Dec 31, 2022 | -0.20% |
| Mar 31, 2022 | 41.96% |